Advertisement
Proffered Papers: Brachytherapy 2: Prostate HDR| Volume 115, SUPPLEMENT 1, S45, April 2015

OC-0089: Phase II trial of dose escalation to dominant intraprostatic lesion with TRUS-MRI guided real time HDR brachytherapy

Open AccessDOI:https://doi.org/10.1016/S0167-8140(15)40089-1
OC-0089: Phase II trial of dose escalation to dominant intraprostatic lesion with TRUS-MRI guided real time HDR brachytherapy
Previous ArticleOC-0088: Evaluation of dose-predictors of urethral strictures for prostate patients treated with HDR brachytherapy
Next ArticleOC-0090: Salvage HDR-brachytherapy for previously irradiated locally recurrent prostate cancer
      This paper is only available as a PDF. To read, Please Download here.

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0167-8140(15)40089-1

      Copyright

      © 2015 Elsevier Ireland Ltd. Published by Elsevier Inc.

      User license

      Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
      How you can reuse Information Icon
      Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Redistribute or republish the final article
      • Text & data mine
      • Translate the article (private use only, not for distribution)
      • Reuse portions or extracts from the article in other works

      Not Permitted

      • Sell or re-use for commercial purposes
      • Distribute translations or adaptations of the article

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX